Drug management in the elderly adult with chronic kidney disease: A review for the primary care physician

Claudio Ponticelli, Gabriele Sala, Richard J. Glassock

Research output: Contribution to journalArticle

Abstract

With advancing age, the functional reserve of many organs tends to decrease. In particular, the lean body mass, the levels of serum albumin, the blood flow to the liver, and the glomerular filtration rate are reduced in elderly individuals and can be further impaired by the concomitant presence of acute or chronic kidney disease. Moreover, patients with kidney disease are often affected by comorbid processes and are prescribed multiple medications. The aging process also modifies some drug interactions, including the affinity of some drugs for their receptor, the number of receptors, and the cell responses upon receptor activation. Therefore, older patients with kidney disease are particularly susceptible to the risks of adverse drug reactions. Planning a pharmacological regimen in such patients is confounded by the paucity of information available on the pharmacokinetic and pharmacodynamic profiles of a large number of drugs commonly used in this group of patients. Finally, many aged patients suffer from unintentional poor compliance. In this review, the problems physicians face in designing safe and effective medication management in elderly individuals are discussed, paying attention to those more frequently used, which may be potentially harmful in patients with kidney disease. The risks of overdosing and underdosing are outlined, and some recommendations to reduce the risk of adverse drug reactions are provided. A review of the literature covering the field of drug management in older patients with kidney disease was performed by selecting those articles published between January 1, 1990, and December 1, 2014, using PubMed as a search engine with the keywords elderly, kidney disease, drugs, drug interaction, and renal function.

Original languageEnglish
Pages (from-to)633-645
Number of pages13
JournalMayo Clinic Proceedings
Volume90
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Primary Care Physicians
Chronic Renal Insufficiency
Kidney Diseases
Pharmaceutical Preparations
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Drug Receptors
Search Engine
Glomerular Filtration Rate
PubMed
Serum Albumin
Pharmacokinetics
Cell Count
Pharmacology
Physicians
Kidney
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Drug management in the elderly adult with chronic kidney disease : A review for the primary care physician. / Ponticelli, Claudio; Sala, Gabriele; Glassock, Richard J.

In: Mayo Clinic Proceedings, Vol. 90, No. 5, 01.05.2015, p. 633-645.

Research output: Contribution to journalArticle

Ponticelli, Claudio ; Sala, Gabriele ; Glassock, Richard J. / Drug management in the elderly adult with chronic kidney disease : A review for the primary care physician. In: Mayo Clinic Proceedings. 2015 ; Vol. 90, No. 5. pp. 633-645.
@article{2acbe0aebd5f4c1689a206a984eb98aa,
title = "Drug management in the elderly adult with chronic kidney disease: A review for the primary care physician",
abstract = "With advancing age, the functional reserve of many organs tends to decrease. In particular, the lean body mass, the levels of serum albumin, the blood flow to the liver, and the glomerular filtration rate are reduced in elderly individuals and can be further impaired by the concomitant presence of acute or chronic kidney disease. Moreover, patients with kidney disease are often affected by comorbid processes and are prescribed multiple medications. The aging process also modifies some drug interactions, including the affinity of some drugs for their receptor, the number of receptors, and the cell responses upon receptor activation. Therefore, older patients with kidney disease are particularly susceptible to the risks of adverse drug reactions. Planning a pharmacological regimen in such patients is confounded by the paucity of information available on the pharmacokinetic and pharmacodynamic profiles of a large number of drugs commonly used in this group of patients. Finally, many aged patients suffer from unintentional poor compliance. In this review, the problems physicians face in designing safe and effective medication management in elderly individuals are discussed, paying attention to those more frequently used, which may be potentially harmful in patients with kidney disease. The risks of overdosing and underdosing are outlined, and some recommendations to reduce the risk of adverse drug reactions are provided. A review of the literature covering the field of drug management in older patients with kidney disease was performed by selecting those articles published between January 1, 1990, and December 1, 2014, using PubMed as a search engine with the keywords elderly, kidney disease, drugs, drug interaction, and renal function.",
author = "Claudio Ponticelli and Gabriele Sala and Glassock, {Richard J.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.mayocp.2015.01.016",
language = "English",
volume = "90",
pages = "633--645",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Drug management in the elderly adult with chronic kidney disease

T2 - A review for the primary care physician

AU - Ponticelli, Claudio

AU - Sala, Gabriele

AU - Glassock, Richard J.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - With advancing age, the functional reserve of many organs tends to decrease. In particular, the lean body mass, the levels of serum albumin, the blood flow to the liver, and the glomerular filtration rate are reduced in elderly individuals and can be further impaired by the concomitant presence of acute or chronic kidney disease. Moreover, patients with kidney disease are often affected by comorbid processes and are prescribed multiple medications. The aging process also modifies some drug interactions, including the affinity of some drugs for their receptor, the number of receptors, and the cell responses upon receptor activation. Therefore, older patients with kidney disease are particularly susceptible to the risks of adverse drug reactions. Planning a pharmacological regimen in such patients is confounded by the paucity of information available on the pharmacokinetic and pharmacodynamic profiles of a large number of drugs commonly used in this group of patients. Finally, many aged patients suffer from unintentional poor compliance. In this review, the problems physicians face in designing safe and effective medication management in elderly individuals are discussed, paying attention to those more frequently used, which may be potentially harmful in patients with kidney disease. The risks of overdosing and underdosing are outlined, and some recommendations to reduce the risk of adverse drug reactions are provided. A review of the literature covering the field of drug management in older patients with kidney disease was performed by selecting those articles published between January 1, 1990, and December 1, 2014, using PubMed as a search engine with the keywords elderly, kidney disease, drugs, drug interaction, and renal function.

AB - With advancing age, the functional reserve of many organs tends to decrease. In particular, the lean body mass, the levels of serum albumin, the blood flow to the liver, and the glomerular filtration rate are reduced in elderly individuals and can be further impaired by the concomitant presence of acute or chronic kidney disease. Moreover, patients with kidney disease are often affected by comorbid processes and are prescribed multiple medications. The aging process also modifies some drug interactions, including the affinity of some drugs for their receptor, the number of receptors, and the cell responses upon receptor activation. Therefore, older patients with kidney disease are particularly susceptible to the risks of adverse drug reactions. Planning a pharmacological regimen in such patients is confounded by the paucity of information available on the pharmacokinetic and pharmacodynamic profiles of a large number of drugs commonly used in this group of patients. Finally, many aged patients suffer from unintentional poor compliance. In this review, the problems physicians face in designing safe and effective medication management in elderly individuals are discussed, paying attention to those more frequently used, which may be potentially harmful in patients with kidney disease. The risks of overdosing and underdosing are outlined, and some recommendations to reduce the risk of adverse drug reactions are provided. A review of the literature covering the field of drug management in older patients with kidney disease was performed by selecting those articles published between January 1, 1990, and December 1, 2014, using PubMed as a search engine with the keywords elderly, kidney disease, drugs, drug interaction, and renal function.

UR - http://www.scopus.com/inward/record.url?scp=84929024629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929024629&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.01.016

DO - 10.1016/j.mayocp.2015.01.016

M3 - Article

C2 - 25771152

AN - SCOPUS:84929024629

VL - 90

SP - 633

EP - 645

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -